Ligand Pharmaceuticals (United States)

About

In recent decades, authors affiliated with Ligand Pharmaceuticals (United States) have published 529 papers, which have received a total of 33.4k indexed citations. Scholars at this organization have produced 308 papers in Molecular Biology, 213 papers in Genetics and 85 papers in Oncology on the topics of Estrogen and related hormone effects (196 papers), Retinoids in leukemia and cellular processes (156 papers) and Antioxidant Activity and Oxidative Stress (41 papers). Their work is cited by papers focused on Molecular Biology (19.9k citations), Genetics (10.2k citations) and Oncology (5.3k citations). Authors at Ligand Pharmaceuticals (United States) collaborate with scholars in United States, France and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Ligand Pharmaceuticals (United States)'s most productive authors include Richard A. Heyman, Ronald M. Evans, William W. Lamph, Daniel J. Noonan, Robert B. Stein, A. Negro‐Vilar, Donald P. McDonnell, David J. Mangelsdorf, Mark E. Goldman and Steven A. Kliewer.

In The Last Decade

Ligand Pharmaceuticals (United States)

525 papers receiving 33.4k citations

Countries citing scholars working at Ligand Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Ligand Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ligand Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligand Pharmaceuticals (United States) more than expected).

Fields of papers published by authors at Ligand Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Ligand Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ligand Pharmaceuticals (United States) at the time of their publication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at American Association For The Advancement of Science Breakdown of academic impact, for scholars at International Institute of Tropical Forestry Breakdown of academic impact, for scholars at Fujirebio (Belgium) Breakdown of academic impact, for scholars at Allen Institute for Artificial Intelligence Breakdown of academic impact, for scholars at PDL BioPharma (United States) Breakdown of academic impact, for scholars at Baxter (Sweden) Breakdown of academic impact, for scholars at Oulu Deaconess Institute Breakdown of academic impact, for scholars at Google (United Kingdom)